Expression profile and prognostic role of sex hormone receptors in gastric cancer

[1]  Ying Chen,et al.  Expression profile and prognostic role of sex hormone receptors in gastric cancer , 2012, BMC Cancer.

[2]  Y. Mok,et al.  Expression of estrogen receptors in gastric cancer and their clinical significance , 2012, Journal of surgical oncology.

[3]  H. Sasano,et al.  Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma , 2012, Expert opinion on therapeutic targets.

[4]  J. Gustafsson,et al.  The different roles of ER subtypes in cancer biology and therapy , 2011, Nature Reviews Cancer.

[5]  Rachel Schiff,et al.  Mechanisms of endocrine resistance in breast cancer. , 2011, Annual review of medicine.

[6]  Raj Kumar,et al.  Steroid hormone receptors in cancer development: a target for cancer therapeutics. , 2011, Cancer letters.

[7]  Jiaqi Guo,et al.  Estrogen receptor beta variants mRNA expressions in gastric cancer tissues and association with clinicopathologic parameters. , 2010, Hepato-gastroenterology.

[8]  J. Shen,et al.  Prognostic Role of Estrogen Receptor α and Estrogen Receptor β in Gastric Cancer , 2010, Annals of Surgical Oncology.

[9]  I. Wistuba,et al.  Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation , 2009, Clinical Cancer Research.

[10]  J. Lagergren,et al.  Oestrogen and the enigmatic male predominance of gastric cancer. , 2008, European journal of cancer.

[11]  S. Hurvitz,et al.  Rational management of endocrine resistance in breast cancer , 2008, Cancer.

[12]  G. Chen,et al.  Estrogen and its receptors in cancer , 2008, Medicinal research reviews.

[13]  S. Hayashi,et al.  Estrogen signaling pathway and hormonal therapy , 2008, Breast cancer.

[14]  C. Evans,et al.  Managing prostate cancer: the role of hormone therapy. , 2007, The Canadian journal of urology.

[15]  M. Wang,et al.  Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  K. Sugimachi,et al.  Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor-positive tumors in human adenocarcinomas of the gastrointestinal tract , 1998, Surgery Today.

[17]  O. Kojima,et al.  The prognosis of patients with gastric cancer possessing sex hormone receptors , 2004, Surgery Today.

[18]  H. Yokozaki,et al.  Estrogen receptors in gastric adenocarcinoma: A retrospective immunohistochemical analysis , 2004, Virchows Archiv A.

[19]  A. Papavassiliou,et al.  Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[20]  Kei Nakachi,et al.  Estrogen receptor β is expressed in human stomach adenocarcinoma , 2002, Journal of Cancer Research and Clinical Oncology.

[21]  N. Iizuka,et al.  Expression of estrogen receptor-α and -β mRNAs in human gastric cancer , 2002 .

[22]  N. Iizuka,et al.  Expression of estrogen receptor-alpha and -beta mRNAs in human gastric cancer. , 2002, Cancer letters.

[23]  Kei Nakachi,et al.  Estrogen receptor beta is expressed in human stomach adenocarcinoma. , 2002, Journal of cancer research and clinical oncology.

[24]  Á. Pascual,et al.  Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.

[25]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[26]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[27]  C. Oshima,et al.  Estrogen and progesterone receptors in gastric and colorectal cancer. , 1999, Hepato-gastroenterology.

[28]  I. Brotherick,et al.  Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study , 1999, British Journal of Cancer.

[29]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[30]  H. Bouzourène,et al.  Estrogen and progesterone receptors and pS2 and ERD5 antigens in gastric carcinomas from the European population. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[31]  A. Lazaris,et al.  Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma , 1995, Journal of surgical oncology.

[32]  M. Sobrinho-Simões,et al.  Female sex hormone receptors are not involved in gastric carcinogenesis. A biochemical and immunohistochemical study , 1994, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[33]  W. McGuire,et al.  Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. , 1993, Journal of the National Cancer Institute.

[34]  C. Chi,et al.  Hormonal therapy for stomach cancer. , 1992, Medical hypotheses.

[35]  C. Chi,et al.  The nontransformed progesterone and estrogen receptors in gastric cancer. , 1992, Gastroenterology.

[36]  C. Chi,et al.  Sex hormone receptors in gastric cancer , 1990, Cancer.

[37]  I. Ellis,et al.  The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma , 1989, Cancer.

[38]  G. Asano,et al.  Estrogen and Progesterone Receptors in Gastric Cancer , 1986, Cancer.

[39]  A. Weisz,et al.  Estradiol and progesterone receptors in malignant gastrointestinal tumors. , 1984, Cancer research.

[40]  G. Asano,et al.  Hormone receptors in gastric cancer. , 1983, European journal of cancer & clinical oncology.